share_log

Intra-Cellular Therapies Q1 2024 GAAP EPS $(0.16) Beats $(0.32) Estimate, Sales $144.866M Beat $141.381M Estimate

Benzinga ·  May 7 19:32
Intra-Cellular Therapies Q1 2024 GAAP EPS $(0.16) Beats $(0.32) Estimate, Sales $144.866M Beat $141.381M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment